Southport Capital Management’s Teva Pharmaceuticals TEVA Stock Holding History

Southport Capital Management’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-3,075	Closed	-$66K	–	464
2018 Q3	$66K	Buy	+3,075	New	+$71.4K	0.03%	231
2017 Q2	–	Sell	-6,815	Closed	-$219K	–	181
2017 Q1	$219K	Sell	6,815 -4,905	-42%	-$167K	0.12%	148
2016 Q4	$425K	Sell	11,720 -6,727	-36%	-$269K	0.26%	104
2016 Q3	$849K	Sell	18,447 -930	-5%	-$48.5K	0.59%	61
2016 Q2	$973K	Hold	19,377	–	–	0.54%	55
2016 Q1	$1.04M	Hold	19,377	–	–	0.67%	53
2015 Q4	$1.27M	Sell	19,377 -75	-0.4%	-$4.63K	0.82%	42
2015 Q3	$1.1M	Sell	19,452 -150	-0.8%	-$9.73K	0.74%	48
2015 Q2	$1.16M	Sell	19,602 -3,170	-14%	-$196K	0.7%	51
2015 Q1	$1.42M	Hold	22,772	–	–	0.84%	40
2014 Q4	$1.31M	Buy	22,772 +160	+0.7%	+$8.91K	0.78%	45
2014 Q3	$1.22M	Hold	22,612	–	–	0.8%	45
2014 Q2	$1.19M	Hold	22,612	–	–	0.79%	45
2014 Q1	$1.2M	Sell	22,612 -15	-0.1%	-$693	0.84%	43
2013 Q4	$907K	Sell	22,627 -1,945	-8%	-$76.6K	0.64%	52
2013 Q3	$928K	Sell	24,572 -158	-0.6%	-$6.16K	0.72%	45
2013 Q2	$969K	Buy	+24,730	New	+$963K	0.79%	39

Other funds holding TEVA

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Berkshire Hathaway Omaha, Nebraska $263B AUM 16.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ACM

Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return

Brahman Capital New York $275M AUM 18.08% 1-Year Est. Return

HCM

Highfields Capital Management Boston, Massachusetts $68.3M AUM 21.64% 1-Year Est. Return

Southport Capital Management's TEVA Position: Q4 2018 in Review

Southport Capital Management sold out of Teva Pharmaceuticals (TEVA) in Q4 2018, closing a stake of 3,075 shares — an estimated $66K sold.

Southport Capital Management first reported a position in TEVA in Q2 2013 and held it in 17 quarters. The position peaked at $1.42M in Q1 2015. 551 funds tracked by Wall St. Rank hold TEVA as of Q4 2018.

Southport Capital Management reported no remaining Teva Pharmaceuticals position as of Q4 2018 after selling out during the quarter.
Southport Capital Management sold 3,075 Teva Pharmaceuticals shares in Q4 2018, an estimated $66K.
Southport Capital Management first reported a position in Teva Pharmaceuticals in Q2 2013 and held it in 17 quarters.
Southport Capital Management's Teva Pharmaceuticals position peaked at $1.42M in Q1 2015.
551 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q4 2018.

Based on Southport Capital Management's 13F filing for Q4 2018, filed 18 Jan 2019.